Literature DB >> 17142158

ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease.

Janine E Bullard1, Susan E Wert, Lawrence M Nogee.   

Abstract

ABCA3 is a member of the ATP Binding Cassette family of proteins, transporters that hydrolyze ATP in order to move substrates across biological membranes. Mutations in the gene encoding ABCA3 have been found in children with severe neonatal respiratory disease and older children with some forms of interstitial lung disease. This review summarizes current knowledge concerning clinical, genetic, and pathologic features of the lung disease associated with mutations in the ABCA3 gene, and also briefly reviews some other forms of childhood interstitial lung diseases that have their antecedents in the neonatal period and may also have a genetic basis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142158     DOI: 10.1053/j.semperi.2005.12.001

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  21 in total

1.  Disruption of N-linked glycosylation promotes proteasomal degradation of the human ATP-binding cassette transporter ABCA3.

Authors:  Michael F Beers; Ming Zhao; Yaniv Tomer; Scott J Russo; Peggy Zhang; Linda W Gonzales; Susan H Guttentag; Surafel Mulugeta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

Review 2.  Diseases of pulmonary surfactant homeostasis.

Authors:  Jeffrey A Whitsett; Susan E Wert; Timothy E Weaver
Journal:  Annu Rev Pathol       Date:  2015       Impact factor: 23.472

3.  Respiratory distress syndrome due to a novel homozygous ABCA3 mutation in a term neonate.

Authors:  Hussain Parappil; Ahmad Al Baridi; Sajjad ur Rahman; Mahmood H Kitchi; P Ruef; M Griese; P Lohse; C Aslanidis; G Schmitz; L Koch; J Poeschl
Journal:  BMJ Case Rep       Date:  2011-03-03

4.  Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice.

Authors:  Valérie Besnard; Yohei Matsuzaki; Jean Clark; Yan Xu; Susan E Wert; Machiko Ikegami; Mildred T Stahlman; Timothy E Weaver; Alan N Hunt; Anthony D Postle; Jeffrey A Whitsett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-26       Impact factor: 5.464

5.  Synonymous ABCA3 variants do not increase risk for neonatal respiratory distress syndrome.

Authors:  Jennifer A Wambach; Daniel J Wegner; Hillary B Heins; Todd E Druley; Robi D Mitra; Aaron Hamvas; F Sessions Cole
Journal:  J Pediatr       Date:  2014-03-20       Impact factor: 4.406

6.  Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.

Authors:  Hiroshi Kitazawa; Kunihiko Moriya; Hidetaka Niizuma; Kengo Kawano; Yuka Saito-Nanjo; Toru Uchiyama; Takeshi Rikiishi; Yoji Sasahara; Osamu Sakamoto; Yasuhiro Setoguchi; Shigeo Kure
Journal:  Eur J Pediatr       Date:  2013-02-27       Impact factor: 3.183

Review 7.  Emerging concepts in the pathogenesis of lung fibrosis.

Authors:  William D Hardie; Stephan W Glasser; James S Hagood
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

8.  STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells.

Authors:  Yohei Matsuzaki; Valérie Besnard; Jean C Clark; Yan Xu; Susan E Wert; Machiko Ikegami; Jeffrey A Whitsett
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

Review 9.  Genetic disorders of surfactant dysfunction.

Authors:  Susan E Wert; Jeffrey A Whitsett; Lawrence M Nogee
Journal:  Pediatr Dev Pathol       Date:  2009 Jul-Aug

10.  Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-B and ATP binding cassette, subfamily a, member 3 genes.

Authors:  Aaron Hamvas; Lawrence M Nogee; Daniel J Wegner; Kelcey Depass; John Christodoulou; Bruce Bennetts; Leon R McQuade; Peter H Gray; Robin R Deterding; Travis R Carroll; Anja Kammesheidt; Laura M Kasch; Shashikant Kulkarni; F Sessions Cole
Journal:  J Pediatr       Date:  2009-08-03       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.